Imfinzi Interactions
There are 629 drugs known to interact with Imfinzi (durvalumab), along with 11 disease interactions. Of the total drug interactions, 25 are major, 603 are moderate, and 1 is minor.
- View all 629 medications that may interact with Imfinzi
- View Imfinzi disease interactions (11)
Most frequently checked interactions
View interaction reports for Imfinzi (durvalumab) and the medicines listed below.
- acetaminophen
- Adcirca (tadalafil)
- albuterol
- amlodipine
- amoxicillin
- amoxicillin / clavulanate
- aspirin
- atorvastatin
- azithromycin
- Benadryl (diphenhydramine)
- biotin
- carboplatin
- Claritin (loratadine)
- colchicine
- dexamethasone
- Eliquis (apixaban)
- gabapentin
- ibuprofen
- lisinopril
- losartan
- metformin
- ondansetron
- pantoprazole
- prednisone
- prochlorperazine
- rosuvastatin
- tamsulosin
- Taxol (paclitaxel)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Vitamin D3 (cholecalciferol)
Imfinzi disease interactions
There are 11 disease interactions with Imfinzi (durvalumab) which include:
- adrenal insufficiency
- colitis
- diabetes
- infections
- liver dysfunction
- renal dysfunction
- thyroid disorders
- Durvalumab – pneumonitis
- HSCT
- myasthenia gravis
- organ transplant
Report options
More about Imfinzi (durvalumab)
- Imfinzi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Tagrisso
Tagrisso (osimertinib) may be used to treat adults with non-small cell lung cancer (NSCLC) whose ...
Gemcitabine
Gemcitabine is used for breast cancer, breast cancer, metastatic, nasopharyngeal carcinoma, non ...
Nivolumab
Nivolumab is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Paclitaxel
Paclitaxel is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic, kaposi's ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
